---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-238355"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2021-08-06T23:59:59+00:00"
generated_at: "2026-06-29T21:06:39.384749+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mednax Q2: GAAP EPS $0.36, adj EPS $0.41, revenue $473M (+14% YoY), volume strong

## Summary
- Net revenue $473M vs $415.4M prior year; income from cont ops $30.5M ($0.36 diluted) vs $7.1M ($0.08).
- Adjusted EPS $0.41 vs $0.26; adjusted EBITDA $65.5M vs $55.7M.
- Same-unit revenue +13.4% (volume +9.5%, reimbursement +3.9%); office-based services volume +23.2%.
- No CARES Act funds in Q2'21 vs $5.8M in Q2'20; gain on building sale $7.3M excluded from adj metrics.
- Redeemed $750M 5.25% notes due 2023 in Jan 2021; debt now $1.0B with no revolver borrowings.

## SEC filing metadata
- accession: 0001193125-21-238355
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2021-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/0001193125-21-238355-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/d212310d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-238355
- JSON: https://secwatch.observer/filing/0001193125-21-238355.json
- Plain text: https://secwatch.observer/filing/0001193125-21-238355.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.